Gender-Responsive Treatment for Women Offenders - 1

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Michael Prendergast, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00249613
First received: November 3, 2005
Last updated: March 7, 2014
Last verified: March 2014
  Purpose

The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).


Condition Intervention
Substance Abuse Problem
Behavioral: Women-Only

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Gender-Responsive Treatment for Women Offenders

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Results (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatment [ Time Frame: baseline and 1-year follow-up ] [ Designated as safety issue: No ]
  • Predictors of Criminal Activity at 12 Months Post Intake [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
  • Any Substance Use Past 30 Days [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
    Substance use in past 30 days at 12 months post intake


Secondary Outcome Measures:
  • Predictors of Change in Employment at 12 Months Post Intake: Generalized Estimating Equation (GEE) Model [ Time Frame: 12 month post intake ] [ Designated as safety issue: No ]
    Predictors of change in employment at 12 months post intake: GEE - comparison of Women-Only vs. Mixed-Gender treatment models


Enrollment: 291
Study Start Date: June 2005
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Women-Only
Substance abuse treatment program for women only
Behavioral: Women-Only
Gender-responsive treatment for women only
No Intervention: Mixed-Gender
Substance abuse treatment program for both women and men

Detailed Description:

In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Drug court participant
  • At least eighteen (18) years old
  • Have had no more than three prior non-violent, non-drug felony convictions
  • Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs

Exclusion Criteria:

  • Not capable of giving informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00249613

Locations
United States, California
University of California - Los Angeles
Los Angeles, California, United States, 90024
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Principal Investigator: Michael Prendergast, Ph.D. University of California, Los Angeles
  More Information

Publications:
Responsible Party: Michael Prendergast, Research Historian, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT00249613     History of Changes
Other Study ID Numbers: NIDA-16277-1, R01DA016277
Study First Received: November 3, 2005
Results First Received: April 10, 2013
Last Updated: March 7, 2014
Health Authority: United States: Federal Government

Keywords provided by University of California, Los Angeles:
gender-responsive substance abuse treatment

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 22, 2014